DYOR - - - - - - - - - Biom Technologies mid-July 2010 AIM
This is the new resting place for Stanelco, the wonder producer of starch-based food-trays...only they didn't catch on.Over the last 10 years to 2010 the 0.1p shares traded abour 2.5p then shot up to 24p during 2005 with promise of Tray-Trials I understand. Within a year or so, they fell to new depths and finished at 0.2p Of course they were full-list then and some were held in ISA's hoping there would be a big profit...only now these are distressed sales as the Company slunk off to AIM, presumably "...to provide better shareholder-value"
Perhaps someone closer to the Co. can explain why the new name is Biome
....rhymes with Home. Often it is done to remove the previous sp-history.
Could it be..so new investors can bask in ignorance, etc. I'm not aware of any "change" in fortune for SEO, rather the reverse.
In my limited experience, the longer the name of a company the longer you have to wait for any return...Huh . . . . . .
. SEO had been a terrible investment.
DYOR.
Can Biome be any worse...?
EDIT ( 24April2017)- "just woken up" -me not BIOME - sp is 154, but I note about June 2013 there was what looks like a CONsolidation . . do I recall many LT investors were sold-short?... as I believe the (new share) numbers were terrible! . . . Anyone?

yes, a resounding price rise of 0.01p per share on the news of this new contract. retirement beckons.

Well it is half the spread :-)

19 January 2012

Biome Technologies plc

("Biome" or "the Group")

Pre-close Trading Statement

Biome Technologies plc, the bioplastics and RF technology business, is providing a pre-close trading statement for the financial year ended 31 December 2011 ahead of the announcement of the audited Preliminary results.

The Board is pleased to report that it expects the financial performance of Biome for the full year period to be in line with its expectations. Group revenue for the full year exceeded that in 2010 by more than 40% and, as a consequence, a significant reduction in operating loss is anticipated.

In the Bioplastics Division, revenue growth has been encouraging with an increase in revenues across products, applications and geographies. This growth was particularly strong in the first half, with more moderate growth in the second half, due to some market volatility following the easing of previous supply chain constraints. Revenue growth was particularly robust in the wholly owned Biome Bioplastics business as the commercial and technological capability of the team continues to strengthen.

The Stanelco RF Technologies Division saw a further substantial improvement over the course of the year with the continuation of a sizeable fibre optic furnace build programme and additional diversification into new industrial markets.

The Group's cash position at 31 December 2011 was GBP2.4m (30 September 2011: GBP3.0m) and the Group's debt facility of up to GBP2.0m remains unutilised.

As Continental Europe remains a major part of the Group's operations, the Board remains mindful of the wider economic uncertainties that could impact Biome in 2012. However, against this backdrop, incoming order level for the Bioplastics Division is strong and the signing of the previously announced contract between the RF Technologies Division and Durapipe UK provides considerable encouragement for 2012.

The Board feels confident that the Group can continue delivering on its strategy and building a successful business.

The Group expects to publish its Preliminary results for the full year ended 31 December 2011 on 29 March 2012.

-Ends-

loads of buying today...someone know something about patent dispute...nudge,nudge,wink,wink ;-)

Your not wrong there maestro, 29mil buys nearly all blue.,. next xmas hol coming on nicely. Wouldn't want to be out of these over the weekend.,.

A bit of life here this morning - in auction +13.3%.

dunno why though do you?

I guess a tip somewhere - coming off now.

Tipped in Shares mag. Not the first time.

Finals due next Thursday.

Preliminary Results.

Financial Highlights

-- Group revenue up 42% to GBP19.1m
-- Loss from operations reduced to GBP1.0m (2010: loss GBP1.9m), ahead of expectations
-- Loss before tax reduced to GBP1.1m (2010: loss GBP2.3m)
-- Closing Group cash position GBP2.4m
-- Two year debt facility of up to GBP2.0m agreed in May 2011 to support the continued growth of the Group

Business Highlights

-- 47% growth in Bioplastics Division revenue which includes:
- 82% growth in revenue made by Biome Bioplastics, the wholly owned UK headquartered bioplastics business

- 31% growth in Biotec's third party revenue
-- 21% growth in revenue in Stanelco RF Technologies with a new contract signed with Durapipe UK in January 2012

-- Bioplastics Division reaches annual breakeven for the first time and Stanelco RF Technologies improves profitability

-- Significant progress made in broadening the Group's customer base in both applications and geography

-- Board strengthened with the appointment of Declan Brown as Group Finance Director

So maybe next year we actually may see some profit!!!!!!!!

Maybe!

50p by Christmas 2062?

now that would be a good 112th birthday pressie- better start living a bit more cleanly for that to happen I guess-where would I spent it on by then?????

A couple of champagne pills, followed by a fillet steak dinner pill no doubt, all whilst suspended above the ground by jets of warm air, watching wall screen 3D TV!

In your 300 room villa by the Med!

Golly Gosh - Kim is that what they will be providing in Heaven in 2062? Something to look forward to then!!

Hi Kimoldfield,

In 2062, I will be 114, so I will look forward to Wine and Women, didnt mention song as at that age my voice wont be up to it.
Like the idea of Champagne and Fillet pills though as my nashers may be getting a bit worn by then.
No smutty comments you lot!

:o)

A "when they were up, they were up" day - currently +23%.